ResearcherKeio UniversityActive in the last 2 years
Yasuaki Kabe
Matched on ORCID iD 0000-0003-0952-011X; OpenAlex author ID A5003243340. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 4
- A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin Combination Using Machine Learning. Last author DOI 10.3390/cancers18060924↗
- Prognosis prediction of PDAC via detection of O-glycan altered extracellular vesicles in perioperative sera. First author DOI 10.1111/cas.16341↗
- Comparative Glycomic Analysis of Exosome Subpopulations Derived from Pancreatic Cancer Cell Lines. Co-author DOI 10.1021/acs.jproteome.0c00200↗
- O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer. First author DOI 10.3390/cancers12092469↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Minoru Kitago · 3 shared papers, 2020–2026 · strength 0.49
- Paper A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin … DOI 10.3390/cancers18060924↗
- Paper Prognosis prediction of PDAC via detection of O-glycan altered extracellular vesicles in perioperative sera. DOI 10.1111/cas.16341↗
- Paper O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer. DOI 10.3390/cancers12092469↗
- Atsushi Kuno · 3 shared papers, 2020–2026 · strength 0.42
- Paper A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin … DOI 10.3390/cancers18060924↗
- Paper Comparative Glycomic Analysis of Exosome Subpopulations Derived from Pancreatic Cancer Cell Lines. DOI 10.1021/acs.jproteome.0c00200↗
- Paper O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer. DOI 10.3390/cancers12092469↗
- Sho Uemura · 2 shared papers, 2024–2026 · strength 0.41
- Tatsuya Kawakami · 2 shared papers, 2024–2026 · strength 0.41
- Ayumi Kashiro · 2 shared papers, 2020–2026 · strength 0.31
- Yuko Kitagawa · 2 shared papers, 2020–2026 · strength 0.31
- Kazufumi Honda · 2 shared papers, 2020–2026 · strength 0.31
- Shutaro Hori · 2 shared papers, 2020–2024 · strength 0.26
- Yuta Abe · 2 shared papers, 2020–2024 · strength 0.26
- Yutaka Nakano · 2 shared papers, 2020–2024 · strength 0.26
- Mutsuo Furihata · 1 shared paper, 2026 · strength 0.23
- Kaoru Furihata · 1 shared paper, 2026 · strength 0.23
- Atsushi Matsuda · 2 shared papers, 2020 · strength 0.18
- Yuko Kitagawa · 1 shared paper, 2024 · strength 0.18
- Yasunori Sato · 1 shared paper, 2024 · strength 0.18
- Masayuki Tanaka · 1 shared paper, 2024 · strength 0.18
- Takanori Wagatsuma · 1 shared paper, 2020 · strength 0.11
- Hisashi Narimatsu · 1 shared paper, 2020 · strength 0.11
- Takahiro Yokose · 1 shared paper, 2020 · strength 0.07
- Satoshi Nara · 1 shared paper, 2020 · strength 0.07
- Yohei Masugi · 1 shared paper, 2020 · strength 0.07
- Michiie Sakamoto · 1 shared paper, 2020 · strength 0.07
- Chigusa Morizane · 1 shared paper, 2020 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.